Cite

HARVARD Citation

    Zhang, P. et al. (2020). Developing protein arginine methyltransferase 1 (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systems. Drug delivery. pp. 491-501. [Online]. 
  
Back to record